Dr. Xiaokui Zhang (left), Dr. Albert Wong (center), and Dr. Preet Chaudhary (right) Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at Celularity to conduct a clinical trial for the treatment of COVID-19. This brings the total number of CIRM clinical trials to 64, including … Continue reading CIRM Board Approves Third Clinical Trial for COVID-19
Dr. Albert Wong
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) The COVID-19 virus targets many different parts of the body, often with deadly or life-threatening consequences. This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19